192 related articles for article (PubMed ID: 18343311)
1. Thyroid cancer guidelines--what's new?
Gerrard G; Gill V
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):264-6. PubMed ID: 18343311
[No Abstract] [Full Text] [Related]
2. Thyroid reports: insight into radioiodine ablation and new guidelines for nodule management.
J Nucl Med; 2006 Mar; 47(3):15N, 26N. PubMed ID: 16594104
[No Abstract] [Full Text] [Related]
3. [Treatment of autonomic thyroid gland adenomas].
Pickardt CR
Dtsch Med Wochenschr; 1978 Jun; 103(22):922-3. PubMed ID: 207502
[No Abstract] [Full Text] [Related]
4. [The treatment of differentiated thyroid cancer].
Hubold C; Buchmann I; Lehnert H
Dtsch Med Wochenschr; 2011 Apr; 136(17):891-5. PubMed ID: 21523640
[No Abstract] [Full Text] [Related]
5. Long-term recurrence of thyroid cancer after thyroid remnant ablation with 1.1 and 3.7 GBq radioiodine.
Rosário PW; Purisch S; Vasconcelos FP; Padrão EL; Rezende LL; Barroso AL
Nucl Med Commun; 2007 Jun; 28(6):507-8. PubMed ID: 17460543
[No Abstract] [Full Text] [Related]
6. [Non-surgical treatment of thyroid neoplasms].
Klepp O
Tidsskr Nor Laegeforen; 1975 Aug; 95(23):1287-90. PubMed ID: 1179338
[No Abstract] [Full Text] [Related]
7. [Classification of the malignant struma and its combined treatment].
Röher HD
Med Welt; 1969 Jun; 26():1480-4. PubMed ID: 5801900
[No Abstract] [Full Text] [Related]
8. The 2009 American Thyroid Association guidelines modestly reduced radioactive iodine use for thyroid cancers less than 1 cm.
Roman BR; Feingold JH; Patel SG; Shaha AR; Shah JP; Tuttle RM; Epstein AJ
Thyroid; 2014 Oct; 24(10):1549-50. PubMed ID: 25065817
[No Abstract] [Full Text] [Related]
9. [Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer].
Dietlein M; Dressler J; Farahati J; Leisner B; Moser E; Reiners C; Schicha H; Schober O
Nuklearmedizin; 1999; 38(6A):221-2. PubMed ID: 10510812
[No Abstract] [Full Text] [Related]
10. Treatment of thyroid cancer.
Potter JF
Am Fam Physician; 1972 Oct; 6(4):76-7. PubMed ID: 5079758
[No Abstract] [Full Text] [Related]
11. Thyroid cancer: an overview.
Haq M; Harmer C
Nucl Med Commun; 2004 Sep; 25(9):861-7. PubMed ID: 15319589
[No Abstract] [Full Text] [Related]
12. Thyroid gland: thyroid surgery and radioiodine ablation-the surgeon's role.
Luster M; Musholt TJ
Nat Rev Endocrinol; 2013 Mar; 9(3):140-1. PubMed ID: 23183674
[No Abstract] [Full Text] [Related]
13. The HiLo trial: a multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer.
Mallick U; Harmer C; Hackshaw A
Clin Oncol (R Coll Radiol); 2008 Jun; 20(5):325-6. PubMed ID: 18474322
[No Abstract] [Full Text] [Related]
14. Applying the radioactive eraser: I-131 to ablate normal thyroid tissue in patients from whom thyroid cancer has been resected.
Sisson JC
J Nucl Med; 1983 Aug; 24(8):743-5. PubMed ID: 6875686
[No Abstract] [Full Text] [Related]
15. A new age for recombinant human thyroid-stimulating hormone?
Medvedec M
J Nucl Med; 2009 May; 50(5):832; author reply 832-3. PubMed ID: 19372486
[No Abstract] [Full Text] [Related]
16. New frontiers and treatment paradigms for thyroid carcinoma.
Haddad R; Sherman SI; Shah JP; Wirth LJ
Clin Adv Hematol Oncol; 2014 Jul; 12(7 Suppl 14):3-21; quiz 22. PubMed ID: 25768715
[No Abstract] [Full Text] [Related]
17. [Malignant goiter].
Fischer M; Buttermann G; Becker G; Hör G; Theisinger W
Fortschr Med; 1973 Oct; 91(29):1159-64. PubMed ID: 4748917
[No Abstract] [Full Text] [Related]
18. Current issues in the management of differentiated thyroid cancer.
Mallick UK; Charalambous H
Nucl Med Commun; 2004 Sep; 25(9):873-81. PubMed ID: 15319591
[No Abstract] [Full Text] [Related]
19. [Our attitude towards the treatment of thyroid cancer (a report of 50 cases ) (author's transl)].
Mellière D; Hazard J; Galle P; Scattolini G; Bertin P; Moretti ; Perlemuter L; Bernheim R; Gouygou C; Lange F
Ann Endocrinol (Paris); 1974; 35(3):285-6. PubMed ID: 4463796
[No Abstract] [Full Text] [Related]
20. Post-surgical thyroid ablation in intermediate risk-differentiated thyroid cancer patients.
Rosario PW
Eur J Endocrinol; 2013 Nov; 169(5):L1. PubMed ID: 24084443
[No Abstract] [Full Text] [Related]
[Next] [New Search]
